Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to compare the safety and efficacy of nicotinamide mononucleotide (NMN) and placebo in patients with mild ulcerative colitis (UC). The main question it aims to answe...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
The Third Xiangya Hospital of Central South University
NCT05666960 · Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate, and more
NCT04102852 · Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate
NCT05538026 · Ulcerative Colitis Chronic Mild, Inflammatory Bowel Diseases
NCT03923478 · Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate
The Third Xiangya Hospital of Central South University
Changsha, Hunan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions